These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17175893)

  • 21. Glycogen storage disease type II in Israel.
    Bashan N; Potashnik R; Barash V; Gutman A; Moses SW
    Isr J Med Sci; 1988; 24(4-5):224-7. PubMed ID: 3132435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
    Oral I; Mistrík J; Náplava R
    Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme replacement therapy in severe adult-onset glycogen storage disease type II.
    Ravaglia S; Danesino C; Pichiecchio A; Repetto A; Poloni GU; Rossi M; Fratino P; Moglia A; Costa A
    Adv Ther; 2008 Aug; 25(8):820-9. PubMed ID: 18704279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
    Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
    Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of alglucosidase alfa in late-onset Pompe's disease.
    van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA
    N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
    O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
    J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyopathy in Pompe's disease.
    Fayssoil A
    Eur J Intern Med; 2008 Jan; 19(1):57-9. PubMed ID: 18206603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case report of anesthesia for a child with Pompe's disease (glycogen storage disease type II)].
    Sakakibara M; Teramoto Y; Aoyama T; Takahashi T; Hara M; Maseki M; Yamaguchi S; Nakata J
    Masui; 2009 Feb; 58(2):219-22. PubMed ID: 19227183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.
    Nozohoor S; Nilsson J; Lührs C; Roijer A; Algotsson L; Sjögren J
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):161-5. PubMed ID: 19167912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a de novo point mutation resulting in infantile form of Pompe's disease.
    Lin CY; Shieh JJ
    Biochem Biophys Res Commun; 1995 Mar; 208(2):886-93. PubMed ID: 7695647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nightly home artificial respiration in juvenile Pompe's disease with pulmonary hypertension and right cardiac insufficiency].
    Budde-Steffen C; Grävinghoff L; Albani M; Hellwege HH; Kohlschütter A
    Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1114-6. PubMed ID: 2663410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infantile-acute acid maltase deficiency (Pompe's disease): studies of muscle cultures.
    Meola G; Scarpini E; Manfredi L; Velicogna M; Pellegrini G; Redi CA; Scarlato G
    Basic Appl Histochem; 1984; 28(3):245-55. PubMed ID: 6440527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of antibodies to recombinant enzyme in Pompe's disease.
    Mendelsohn NJ; Messinger YH; Rosenberg AS; Kishnani PS
    N Engl J Med; 2009 Jan; 360(2):194-5. PubMed ID: 19129538
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
    Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
    Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.
    Amalfitano A; Bengur AR; Morse RP; Majure JM; Case LE; Veerling DL; Mackey J; Kishnani P; Smith W; McVie-Wylie A; Sullivan JA; Hoganson GE; Phillips JA; Schaefer GB; Charrow J; Ware RE; Bossen EH; Chen YT
    Genet Med; 2001; 3(2):132-8. PubMed ID: 11286229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Late infantile form of Pompe's disease. Deficiency of alpha-1,4-glucosidase (acid maltase)].
    Colomer J; Roig M; Campistol J; Rullan G; Fernández-Alvarez E
    An Esp Pediatr; 1984 Sep; 21(3):250-9. PubMed ID: 6391315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.